Latest Business Development News

4DMedical Limited has raised $150 million through a well-supported institutional placement to accelerate the commercialisation of its innovative lung imaging product CT – VQ™ in the US market. The capital raise comes with minimal dilution and increased insider confidence.

Neometals and Mineral Resources’ joint venture Reed Advanced Materials has teamed up with electrochemical leader De Nora to pilot an integrated lithium hydroxide production plant, advancing sustainable battery materials technology.

Key Petroleum Limited has appointed Jujun Zhang as Executive Director, CEO, and Vice Chairman, bringing over two decades of new energy expertise to the boardroom. This leadership addition signals a strategic focus on growth and investment in power generation technologies.

ChemX Materials Limited has completed its Deed of Company Arrangement and appointed a new board, yet remains suspended from ASX trading while relying on director-related funding. The company is focused on stabilisation and exploring future opportunities.

Estrella Resources appoints Robert Mencel as CEO, transitioning to Managing Director by mid-2026, to spearhead its limestone and manganese projects in Timor-Leste. The leadership reshuffle aims to accelerate development and operational ramp-up.

EcoGraf Limited has strengthened its cash position with a $1.7 million Australian R&D tax incentive and is pursuing €4 million in European grants to advance its graphite business across Tanzania and Europe.

Elsight has transitioned from development to production with its new Aura communications platform, delivering initial units to a leading defence contractor and expanding its U.S. presence amid a strong financial turnaround in 2025.

Ovanti Limited has raised $3 million through a discounted share placement to fund its expansion into the US buy now, pay later market and support ongoing litigation.

Solstice Minerals reports steady progress in expanding its Nanadie copper-gold resource and promising gold intercepts at Yarri, backed by a strong cash position to fuel 2026 exploration.

PlaySide Studios is gearing up for a pivotal 2026 with its highly anticipated game launch and strategic expansion into the MENAT region, underpinned by strong cost savings and leadership hires.

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.